Terms: = Germ cell tumor AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71 AND Treatment
29 results:
1. The predictive efficacy of programmed cell death in immunotherapy of melanoma: A comprehensive analysis of gene expression data for programmed cell death biomarker and therapeutic target discovery.
Yue C; Lian W; Duan M; Xia D; Cao X; Peng J
Environ Toxicol; 2024 Mar; 39(3):1858-1873. PubMed ID: 38140739
[TBL] [Abstract] [Full Text] [Related]
2. SOX2 downregulation of pml increases HCMV gene expression and growth of glioma cells.
Wen L; Wang XZ; Qiu Y; Zhou YP; Zhang QY; Cheng S; Sun JY; Jiang XJ; Rayner S; Britt WJ; Chen J; Hu F; Li FC; Luo MH; Cheng H
PLoS Pathog; 2023 Apr; 19(4):e1011316. PubMed ID: 37058447
[TBL] [Abstract] [Full Text] [Related]
3. Oleic acid-bound FABP7 drives glioma cell proliferation through regulation of nuclear lipid droplet formation.
Umaru BA; Kagawa Y; Ohsaki Y; Pan Y; Chen CT; Chen DK; Abe T; Shil SK; Miyazaki H; Kobayashi S; Maekawa M; Yamamoto Y; Wannakul T; Yang S; Bazinet RP; Owada Y
FEBS J; 2023 Apr; 290(7):1798-1821. PubMed ID: 36325660
[TBL] [Abstract] [Full Text] [Related]
4. Protein sumoylation with SUMO1 promoted by Pin1 in glioma stem cells augments glioblastoma malignancy.
Zhang A; Tao W; Zhai K; Fang X; Huang Z; Yu JS; Sloan AE; Rich JN; Zhou W; Bao S
Neuro Oncol; 2020 Dec; 22(12):1809-1821. PubMed ID: 32592588
[TBL] [Abstract] [Full Text] [Related]
5. Considerations for using Natalizumab treatment in patients with a history of choroidal melanoma.
Kaye AE; Hawkes ED; Gout II; El-Amir AN; Neffendorf JE
Mult Scler Relat Disord; 2018 Nov; 26():74-76. PubMed ID: 30237107
[TBL] [Abstract] [Full Text] [Related]
6. Anaplastic astrocytoma mimicking progressive multifocal leucoencephalopathy: a case report and review of the overlapping syndromes.
Kantorová E; Bittšanský M; Sivák Š; Baranovičová E; Hnilicová P; Nosáľ V; Čierny D; Zeleňák K; Brück W; Kurča E
BMC Cancer; 2017 Jun; 17(1):424. PubMed ID: 28629398
[TBL] [Abstract] [Full Text] [Related]
7. Induction of senescence in primary glioblastoma cells by serum and TGFβ.
Kumar R; Gont A; Perkins TJ; Hanson JEL; Lorimer IAJ
Sci Rep; 2017 May; 7(1):2156. PubMed ID: 28526854
[TBL] [Abstract] [Full Text] [Related]
8. Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells.
Nukuzuma S; Nakamichi K; Kameoka M; Sugiura S; Nukuzuma C; Tasaki T; Takegami T
Microbiol Immunol; 2016 Apr; 60(4):253-60. PubMed ID: 26935240
[TBL] [Abstract] [Full Text] [Related]
9. Arsenic trioxide disrupts glioma stem cells via promoting pml degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract] [Full Text] [Related]
10. Actinomycin D and nutlin-3a synergistically promote phosphorylation of p53 on serine 46 in cancer cell lines of different origin.
Zajkowicz A; Gdowicz-Kłosok A; Krześniak M; Ścieglińska D; Rusin M
Cell Signal; 2015 Sep; 27(9):1677-87. PubMed ID: 25989210
[TBL] [Abstract] [Full Text] [Related]
11. [A rare case of acute promyelocytic leukemia accompanied by benign craniopharyngioma].
Zhang Q; Yang H; Zhu CY; Niu JH; Xu YY; Wang N; Zhu HY; Yu L; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):660-5. PubMed ID: 24989272
[TBL] [Abstract] [Full Text] [Related]
12. The helicase HAGE prevents interferon-α-induced pml expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract] [Full Text] [Related]
13. Importance of ERK activation in As2O3-induced differentiation and promyelocytic leukemia nuclear bodies formation in neuroblastoma cells.
Petit A; Delaune A; Falluel-Morel A; Goullé JP; Vannier JP; Dubus I; Vasse M
Pharmacol Res; 2013 Nov; 77():11-21. PubMed ID: 24004656
[TBL] [Abstract] [Full Text] [Related]
14. Retinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma.
Masetti R; Biagi C; Zama D; Vendemini F; Martoni A; Morello W; Gasperini P; Pession A
Adv Ther; 2012 Sep; 29(9):747-62. PubMed ID: 22941525
[TBL] [Abstract] [Full Text] [Related]
15. Potential of anti-cancer therapy based on anti-miR-155 oligonucleotides in glioma and brain tumours.
Poltronieri P; D'Urso PI; Mezzolla V; D'Urso OF
Chem Biol Drug Des; 2013 Jan; 81(1):79-84. PubMed ID: 22834637
[TBL] [Abstract] [Full Text] [Related]
16. Type I and II IFNs inhibit Merkel cell carcinoma via modulation of the Merkel cell polyomavirus T antigens.
Willmes C; Adam C; Alb M; Völkert L; Houben R; Becker JC; Schrama D
Cancer Res; 2012 Apr; 72(8):2120-8. PubMed ID: 22389452
[TBL] [Abstract] [Full Text] [Related]
17. Molecular targeting therapy against promyelocytic leukemia protein using arsenic acids in experimental intracranial medulloblastoma.
Gu C; Yokota N; Gao Y; Amano S; Koizumi S; Tokuyama T; Namba H
Neurol Med Chir (Tokyo); 2012; 52(2):62-7. PubMed ID: 22362285
[TBL] [Abstract] [Full Text] [Related]
18. Progressive multifocal leukoencephalopathy in a patient with glioblastoma.
Wu J; Langford LA; Schellingerhout D; Guha-Thakurta N; Tummala S; Weinberg JS; Puduvalli VK
J Neurooncol; 2011 Jul; 103(3):791-6. PubMed ID: 21120583
[TBL] [Abstract] [Full Text] [Related]
19. A pilot study of bevacizumab and interferon-α2b in ocular melanoma.
Guenterberg KD; Grignol VP; Relekar KV; Varker KA; Chen HX; Kendra KL; Olencki TE; Carson WE
Am J Clin Oncol; 2011 Feb; 34(1):87-91. PubMed ID: 20458209
[TBL] [Abstract] [Full Text] [Related]
20. Up-regulation of the embryonic self-renewal network through reversible polyploidy in irradiated p53-mutant tumour cells.
Salmina K; Jankevics E; Huna A; Perminov D; Radovica I; Klymenko T; Ivanov A; Jascenko E; Scherthan H; Cragg M; Erenpreisa J
Exp Cell Res; 2010 Aug; 316(13):2099-112. PubMed ID: 20457152
[TBL] [Abstract] [Full Text] [Related]
[Next]
